(Q28591844)

31 January 2017

title

Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family (English)

1 reference

31 January 2017

1 reference

GOA release 2020-03-11

author name string

K. Tsuchida

1

1 reference

31 January 2017

K. Y. Arai

2

1 reference

31 January 2017

Y. Kuramoto

3

1 reference

31 January 2017

N. Yamakawa

4

1 reference

31 January 2017

Y. Hasegawa

5

1 reference

31 January 2017

H. Sugino

6

1 reference

31 January 2017

language of work or name

English

0 references

publication date

29 December 2000

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

275

1 reference

31 January 2017

issue

52

1 reference

31 January 2017

page(s)

40788–40796

1 reference

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Activin-binding protein from rat ovary is follistatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

A mouse cerberus/Dan-related gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Primary structure of the human follistatin precursor and its genomic organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

A structural superfamily of growth factors containing a cystine knot motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Identification and characterization of a PDZ protein that interacts with activin type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Uterine milk protein, a novel activin-binding protein, is present in ovine allantoic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

SMART, a simple modular architecture research tool: identification of signaling domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Molecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

The heparin binding site of follistatin is involved in its interaction with activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Identification of a binding site on the type II activin receptor for activin and inhibin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

TGF beta inhibitors. New and unexpected requirements in vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Overexpression of mouse follistatin causes reproductive defects in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

cDNA cloning and distribution of the Xenopus follistatin-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Inhibin alpha-subunit monomer is present in bovine follicular fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Localization of the heparin binding site of follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006114200

21 January 2018

Identifiers

DOI

10.1074/JBC.M006114200

1 reference

31 January 2017

1 reference